Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News


Epigenetics research opens potential door to prevent neurodevelopmental disorders

Sai Ma, for­mer Vir­ginia Tech bio­med­ical engi­neer­ing Ph.D. stu­dent, and Chang Lu, the Fred W. Bull pro­fes­sor of Chem­i­cal Engi­neer­ing at Vir­ginia Tech. Cred­it: Vir­ginia Tech


Epi­ge­net­ic Changes Guide Devel­op­ment of Dif­fer­ent Brain Regions (Dana Foun­da­tion):

It’s one of the great­est stand­ing mys­ter­ies in neu­ro­science: Giv­en that each cell in the human body con­tains the same DNA, how, exact­ly, does the brain devel­op into dis­tinct func­tion­al regions, sup­port­ed by dif­fer­ent cell types? And how might that devel­op­men­tal pro­gram go awry, result­ing in neu­rode­vel­op­men­tal dis­or­ders like schiz­o­phre­nia or autism? The answers may be the epigenome, or pro­gram of spe­cif­ic DNA mod­i­fi­ca­tions that affect where, when, and how much a par­tic­u­lar gene will be expressed. Researchers at Vir­ginia Poly­tech­nic Insti­tute and State Uni­ver­si­ty (Vir­ginia Tech) have recent­ly dis­cov­ered sig­nif­i­cant epi­ge­net­ic dif­fer­ences when com­par­ing cells in the cere­bel­lum and the pre­frontal cor­tex of the mouse brain … West says. “The cere­bel­lum devel­ops after birth and it’s entire­ly pos­si­ble that its orga­ni­za­tion is more vul­ner­a­ble to cer­tain kind of insults—insults that can affect the brain’s over­all cir­cuit­ry. Maybe there is some com­mon bio­log­i­cal process, some change to the epigenome, that results in the kind of prob­lems we see in neu­rode­vel­op­men­tal dis­or­ders” …

If we can under­stand the genet­ics and the epi­ge­net­ics of the healthy brain—and then what’s dif­fer­ent in a vari­ety of neu­ro­log­i­cal or neu­ropsy­chi­atric dis­eases, we’ll be in a posi­tion to use these new tech­nolo­gies to inter­vene in the cir­cuit­ry before things go wrong,” he (Chang Lu, chem­i­cal engi­neer at Vir­ginia Tech) says. “This could lead to dis­cov­er­ies that are of direct clin­i­cal rel­e­vance.”

The Study:

Low-input and mul­ti­plexed microflu­idic assay reveals epige­nom­ic vari­a­tion across cere­bel­lum and pre­frontal cor­tex (Sci­enceAd­vances)

  • Abstract: Exten­sive effort is under way to sur­vey the epige­nom­ic land­scape of pri­ma­ry ex vivo tis­sues to estab­lish nor­mal ref­er­ence data and to dis­cern vari­a­tion asso­ci­at­ed with dis­ease. The low abun­dance of some tis­sue types and the iso­la­tion pro­ce­dure required to gen­er­ate a homoge­nous cell pop­u­la­tion often yield a small quan­ti­ty of cells for exam­i­na­tion. This dif­fi­cul­ty is fur­ther com­pound­ed by the need to pro­file a myr­i­ad of epi­ge­net­ic marks. Thus, tech­nolo­gies that per­mit both ultralow input and high through­put are desired. We demon­strate a sim­ple microflu­idic tech­nol­o­gy, Sur­faceChIP-seq, for pro­fil­ing genome-wide his­tone mod­i­fi­ca­tions using as few as 30 to 100 cells per assay and with up to eight assays run­ning in par­al­lel. We applied the tech­nol­o­gy to pro­file epigenomes using nuclei iso­lat­ed from pre­frontal cor­tex and cere­bel­lum of mouse brain. Our cell type–specific data revealed that neu­ronal and glial frac­tions exhib­it­ed pro­found epige­nom­ic dif­fer­ences across the two func­tion­al­ly dis­tinct brain regions.

The Study in Context:

Leave a Reply...

Loading Facebook Comments ...

Leave a Reply

Categories: Cognitive Neuroscience, Education & Lifelong Learning, Health & Wellness, Technology

Tags: , , , , , , , , , , , , , ,

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Search in our archives

Follow us and Engage via…

RSS Feed

Watch All Recordings Now (40+ Speakers, 12+ Hours)